These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2151571)
1. [Doxazosin for the treatment of arterial hypertension]. Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison. Lijnen P; Fagard R; Staessen J; Amery A Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197 [TBL] [Abstract][Full Text] [Related]
4. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin. Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920 [TBL] [Abstract][Full Text] [Related]
5. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial. Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR; Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers. Talseth T; Westlie L; Daae LN J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077 [TBL] [Abstract][Full Text] [Related]
7. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism]. Sznajderman M; Chotkowska E; Peczkowska M; Sawicki M; Janaszek-Sitkowska H; Wiernikowska-Wegorek I; Galewicz A; Cybulska I Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980 [TBL] [Abstract][Full Text] [Related]
8. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study]. Pessina AC Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011 [TBL] [Abstract][Full Text] [Related]
10. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group. J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
12. An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency. Anderton JL; Notghi A J Hum Hypertens; 1990 Oct; 4 Suppl 3():52-7. PubMed ID: 2148196 [TBL] [Abstract][Full Text] [Related]
13. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group. Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385 [TBL] [Abstract][Full Text] [Related]
14. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension. Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390 [TBL] [Abstract][Full Text] [Related]
15. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat. Chichester CO; Rodgers RL J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S21-6. PubMed ID: 2447437 [TBL] [Abstract][Full Text] [Related]
16. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects. Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076 [TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group. Joglekar SJ; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387 [TBL] [Abstract][Full Text] [Related]
18. Doxazosin in hypertension: results of a general practice study in 4809 patients. Langdon CG; Packard RS Br J Clin Pract; 1994; 48(6):293-8. PubMed ID: 7848789 [TBL] [Abstract][Full Text] [Related]
19. [Prazosin in the treatment of hypertension: effect on lipid metabolism]. Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787 [TBL] [Abstract][Full Text] [Related]
20. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group. Joglekar SJ; Jaguste V; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]